XYLXylem Inc.

NYSE xylem.com


$ 139.18 $ 1.99 (1.45 %)    

Monday, 06-May-2024 15:59:57 EDT
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 139.2
$ 137.92
$ 139.17 x 100
$ 0.00 x 0
$ 137.50 - $ 139.18
$ 87.05 - $ 139.21
915,759
na
33.83B
$ 1.13
$ 51.02
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 10-31-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-outperform-on-xylem-raises-price-target-to-162

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $157 to $162.

 oppenheimer-maintains-outperform-on-xylem-raises-price-target-to-147

Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $142 to $147.

 mizuho-maintains-neutral-on-xylem-raises-price-target-to-135

Mizuho analyst Brett Linzey maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $110 to $135.

 baird-maintains-outperform-on-xylem-raises-price-target-to-155

Baird analyst Michael Halloran maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $151 to $155.

 xylem-raises-2024-guidance-now-expects-adj-eps-of-410-to-425-prior-400-420-vs-414-est-sales-guidance-of--85b-prior-84b-85b-vs-8505b-est

Outlook Xylem now expects full-year 2024 revenue of approximately $8.5 billion, up approximately 15 to 16 percent on a reporte...

 xylem-q1-2024-adj-eps-090-beats-084-estimate-sales-2033b-beat-1997b-estimate

Xylem (NYSE:XYL) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.84 by 7.14 perc...

 oppenheimer-maintains-outperform-on-xylem-raises-price-target-to-142

Oppenheimer analyst Bryan Blair maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $133 to $142.

 citigroup-maintains-neutral-on-xylem-raises-price-target-to-139

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $126 to $139.

 baird-maintains-outperform-on-xylem-raises-price-target-to-148

Baird analyst Michael Halloran maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $141 to $148.

 exane-bnp-paribas-initiates-coverage-on-xylem-with-outperform-rating-announces-price-target-of-150

Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Xylem (NYSE:XYL) with a Outperform rating and announces Pri...

 xylem-dexcom-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

 citigroup-maintains-neutral-on-xylem-raises-price-target-to-126

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $122 to $126.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION